[1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:
10.1177/1060028018797110[2] DONG GUN LIM. Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2002, 99 25: 15941-15946. DOI:
10.1073/pnas.232409599[3] FRANCISCO J SCHOPFER. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2005, 102 7: 2340-2345. DOI:
10.1073/pnas.0408384102[4] ÉMERSOM S. LIMA . Nitrated lipids decompose to nitric oxide and lipid radicals and cause vasorelaxation[J]. Free Radical Biology and Medicine, 2005, 39 4: Pages 532-539. DOI:
10.1016/j.freeradbiomed.2005.04.005[5] PAUL R S BAKER. Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2004, 101 32: 11577-11582. DOI:
10.1073/pnas.0402587101[6] PAUL R S BAKER. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands.[J]. The Journal of Biological Chemistry, 2005, 280 51: 42464-42475. DOI:
10.1074/jbc.m504212200
